[VIRTUAL] OLAMKICEPT, AN IL-6 TRANS-SIGNALING INHIBITOR, IS EFFECTIVE FOR INDUCTION OF RESPONSE AND REMISSION IN A RANDOMIZED, PLACEBO-CONTROLLED TRIAL IN MODERATE TO SEVERE ULCERATIVE COLITIS

olamkicept (FE999301) - Ferring

https://eventpilotadmin.com/web/page.php?page=Session&project=DDW21LITE&id=3581651

Baili Chen; Shenghong Zhang; Bangmao Wang; Hong Chen; Yan Li; Qian Cao; Jie Zhong; mingjun xie; Zhihua Ran; Tongyu Tang; michelle yang; taylor guo; beibei xu; Zhiyu Cai; Lijia Ma; Stefan Schreiber; Minhu Chen

May 14, 2021